GaryG Posted January 7, 2021 Share Posted January 7, 2021 Bristol Myers acknowledged defeat withdrawing Optivo's indication in SCLC that has progressed after platinu-base chemo and at least on other line of therapy.\ The development came 2 years after the failure of 2 confirmatory studies, which were meant to turn Optivo's accelerated approval earned in 2018. Link to comment Share on other sites More sharing options...
LouT Posted January 7, 2021 Share Posted January 7, 2021 Always disappointing to hear when a treatment doesn't prove as effective as it was thought to be. Lou Link to comment Share on other sites More sharing options...
Recommended Posts
Archived
This topic is now archived and is closed to further replies.